{"id":11454,"date":"2022-07-01T20:38:32","date_gmt":"2022-07-02T00:38:32","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/methodology-for-combinations-with-icis-moving-to-novel-therapeutics\/"},"modified":"2022-07-14T15:05:47","modified_gmt":"2022-07-14T19:05:47","slug":"2020-mdict-task-force-meeting","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/2020-mdict-task-force-meeting","title":{"rendered":"Methodology for Combinations with ICIs & Moving to Novel Therapeutics"},"content":{"rendered":"

Vanessa M. Lucey, PhD, MBA<\/a>, director of CRI Clinical Accelerator and Venture Fund, is presenting at the Methodology for Combinations with ICIs and Moving to Novel Therapeutics (MDICT) task force meeting on Sunday, March 1, 2020, at 6:00 p.m.<\/strong><\/p>\n

MDICT is a side meeting before ESMO Targeted Anticancer Therapies Congress 2020<\/a>. The MDICT task force was established by the New Drug Development Office (NDDO) Research Foundation in 2006 to provide advice on the development of novel anticancer agents. MDICT has been supported by ESMO since 2018. Speakers at the ESMO Targeted Anticancer Therapies meeting are usually invited. The task force has published a number of recommendations. <\/p>\n

The NDDO Research Foundation<\/a> aims at stimulating improvements in cancer treatment by enhancing the development and introduction into daily practice of new therapies. This aim is pursued by the conduct of research projects and the organization of scientific meetings. <\/p>\n","protected":false},"excerpt":{"rendered":"

CRI's Vanessa Lucey, PhD, MBA, is presenting at the MDICT task force meeting on March 1, 2020 at 6:00 p.m.<\/p>\n","protected":false},"featured_media":4634,"template":"","events_categories":[203],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11454","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-cri-speaks"],"acf":[],"yoast_head":"\nMDICT 2020 in Paris<\/title>\n<meta name=\"description\" content=\"CRI's Vanessa Lucey, PhD, MBA,\u00a0is presenting at MDICT on March 1, 2020 at 6:00 p.m.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MDICT 2020 in Paris\" \/>\n<meta property=\"og:description\" content=\"CRI's Vanessa Lucey, PhD, MBA,\u00a0is presenting at MDICT on March 1, 2020 at 6:00 p.m.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T19:05:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/e2396366-2bf5-4a72-b525-a43cd7b302f3.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"MDICT 2020 in Paris\" \/>\n<meta name=\"twitter:description\" content=\"CRI's Vanessa Lucey, PhD, MBA,\u00a0is presenting at MDICT on March 1, 2020 at 6:00 p.m.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/e2396366-2bf5-4a72-b525-a43cd7b302f3.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting\",\"name\":\"MDICT 2020 in Paris\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c966e6e9-ac22-411d-9c50-2665a098afd7.jpg\",\"datePublished\":\"2022-07-02T00:38:32+00:00\",\"dateModified\":\"2022-07-14T19:05:47+00:00\",\"description\":\"CRI's Vanessa Lucey, PhD, MBA,\u00a0is presenting at MDICT on March 1, 2020 at 6:00 p.m.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c966e6e9-ac22-411d-9c50-2665a098afd7.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c966e6e9-ac22-411d-9c50-2665a098afd7.jpg\",\"width\":700,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Methodology for Combinations with ICIs & Moving to Novel Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MDICT 2020 in Paris","description":"CRI's Vanessa Lucey, PhD, MBA,\u00a0is presenting at MDICT on March 1, 2020 at 6:00 p.m.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting","og_locale":"es_ES","og_type":"article","og_title":"MDICT 2020 in Paris","og_description":"CRI's Vanessa Lucey, PhD, MBA,\u00a0is presenting at MDICT on March 1, 2020 at 6:00 p.m.","og_url":"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T19:05:47+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/e2396366-2bf5-4a72-b525-a43cd7b302f3.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"MDICT 2020 in Paris","twitter_description":"CRI's Vanessa Lucey, PhD, MBA,\u00a0is presenting at MDICT on March 1, 2020 at 6:00 p.m.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/e2396366-2bf5-4a72-b525-a43cd7b302f3.jpg","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting","url":"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting","name":"MDICT 2020 in Paris","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c966e6e9-ac22-411d-9c50-2665a098afd7.jpg","datePublished":"2022-07-02T00:38:32+00:00","dateModified":"2022-07-14T19:05:47+00:00","description":"CRI's Vanessa Lucey, PhD, MBA,\u00a0is presenting at MDICT on March 1, 2020 at 6:00 p.m.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c966e6e9-ac22-411d-9c50-2665a098afd7.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c966e6e9-ac22-411d-9c50-2665a098afd7.jpg","width":700,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/2020-mdict-task-force-meeting#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Methodology for Combinations with ICIs & Moving to Novel Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/4634"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11454"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11454"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11454"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11454"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11454"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11454"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}